KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Current Taxes (2018 - 2026)

Takeda Pharmaceutical has reported Current Taxes over the past 9 years, most recently at $624.1 million for Q1 2026.

  • For Q1 2026, Current Taxes fell 28.67% year-over-year to $624.1 million; the TTM value through Mar 2026 reached $624.1 million, down 28.67%, while the annual FY2026 figure was $650.2 million, 25.81% down from the prior year.
  • Current Taxes was $624.1 million for Q1 2026 at Takeda Pharmaceutical, down from $875.0 million in the prior quarter.
  • Across five years, Current Taxes topped out at $1.8 billion in Q1 2023 and bottomed at $624.1 million in Q1 2026.
  • The 5-year median for Current Taxes is $875.0 million (2025), against an average of $1.1 billion.
  • Year-over-year, Current Taxes rose 26.03% in 2022 and then plummeted 57.78% in 2024.
  • Over 5 years, Current Taxes stood at $1.7 billion in 2022, then rose by 1.61% to $1.8 billion in 2023, then plummeted by 57.78% to $741.6 million in 2024, then rose by 17.99% to $875.0 million in 2025, then decreased by 28.67% to $624.1 million in 2026.
  • The last three reported values for Current Taxes were $624.1 million (Q1 2026), $875.0 million (Q1 2025), and $741.6 million (Q1 2024) per Business Quant data.